Skip to main content
. 2021 Jan 11;6:9. doi: 10.1038/s41541-020-00266-4

Fig. 1. Schematic depicting study design and experiments.

Fig. 1

NAFLD nonalcoholic fatty liver disease, HBsAg hepatitis B surface antigen, Anti-HBs antibody to hepatitis B surface antigen, PBMC peripheral blood mononuclear cells.